Tudor-Eliade C.
- Country
- Romania
- Department
- Medical Oncology
Research Overview
- Phase 1 Study of PAS-004, a MEK (1/2) Inhibitor, in MAPK Pathway-driven Advanced Solid Tumors with RAS, NF1, or RAF Mutations or Post-BRAF/MEK Inhibition Failure
- Pumitamig plus Combination Therapy Versus Nivolumab plus Combination Therapy in Previously Untreated Advanced or Metastatic Gastric, GEJ, or Esophageal Adenocarcinoma
- Phase III Randomized Study of Hetrombopag Olamine Efficacy and Safety in Patients with Chemotherapy-Induced Thrombocytopenia
Data & Insights
Has run more than one trial at 68 of 243 partner sites.
Specializations
Hematologic Malignancies
The investigator concentrates on malignant disorders of the blood and bone marrow.
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Chronic Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Diffuse Large B-Cell Lymphoma
Emphasis on targeted therapies and disease‑modifying strategies.
Thoracic Oncology
Research includes malignant diseases of the lung and mediastinum.
- Non‑Small Cell Lung Cancer
- Small Cell Lung Cancer
- KRAS‑mutant Lung Cancer
- ROS1‑positive NSCLC
- MET‑amplified NSCLC
Investigations address both advanced and early‑stage disease.
Genitourinary Oncology
Investigator studies cancers of the prostate, kidney, and bladder.
- Prostate Adenocarcinoma
- Renal Cell Carcinoma
- Muscle‑Invasive Bladder Cancer
- Non‑muscle‑invasive Bladder Cancer
Focus includes metastatic and high‑risk localized disease.
Gastrointestinal & Hepatobiliary Oncology
Work covers malignancies of the digestive tract and liver.
- Hepatocellular Carcinoma
- Gastric Adenocarcinoma
- Esophageal Squamous Cell Carcinoma
- Colorectal Cancer
- Pancreatic Ductal Adenocarcinoma
Includes studies of tumors with specific molecular alterations.
Breast & Gynecologic Oncology
Investigator addresses breast and female reproductive system cancers.
- Triple‑Negative Breast Cancer
- Hormone‑Receptor Positive Breast Cancer
- HER2‑positive Breast Cancer
- Ovarian Cancer
- Endometrial Cancer
Research spans early‑stage, adjuvant, and metastatic settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.